These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6852993)

  • 41. [Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig].
    Hottinger S; Mettler D; Leupi F; Gertsch M
    Schweiz Med Wochenschr; 1985 Nov; 115(45):1594-6. PubMed ID: 4081686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiarrhythmic actions of amiodarone.
    Anderson GJ
    Am Fam Physician; 1982 Apr; 25(4):178-80. PubMed ID: 6461234
    [No Abstract]   [Full Text] [Related]  

  • 43. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
    Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
    Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term results of treatment with oral amiodarone in patients with malignant ventricular arrhythmias].
    Grande A; Farré J
    Rev Esp Cardiol; 1987; 40(5):317-26. PubMed ID: 3454969
    [No Abstract]   [Full Text] [Related]  

  • 45. Intravenous amiodarone in ventricular fibrillation.
    Chapman JR; Boyd MJ
    Br Med J (Clin Res Ed); 1981 Mar; 282(6268):951-2. PubMed ID: 6781670
    [No Abstract]   [Full Text] [Related]  

  • 46. [The value of electrophysiological studies in the treatment of ventricular tachycardias with amiodarone alone or in combination with class-I anti-arrhythmia drugs].
    Bellocci F; Santarelli P; Montenero S; Nobile A; Spampinato A; Nava S; Zecchi P; Manzoli U
    Cardiologia; 1988 Apr; 33(4):399-405. PubMed ID: 3409264
    [No Abstract]   [Full Text] [Related]  

  • 47. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
    Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
    Sokoloff NM; Spielman SR; Greenspan AM; Rae AP; Brady PM; Kay HR; Horowitz LN
    J Am Coll Cardiol; 1986 Apr; 7(4):938-41. PubMed ID: 3958353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
    J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
    Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
    McKenna WJ; Oakley CM; Krikler DM; Goodwin JF
    Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Value and limitations of electropharmacological tests in the selection of anti-arrhythmic therapy in malignant ventricular tachyarrhythmia].
    Klein H
    Cardiologia; 1985 Jul; 30(7):487-92. PubMed ID: 3834995
    [No Abstract]   [Full Text] [Related]  

  • 54. [Amiodarone in the treatment of disorders of cardiac rhythm. results of six years of clinical experience (author's transl)].
    Van Schepdael J; Solvay H
    Schweiz Rundsch Med Prax; 1975 Jan; 64(2):30-4. PubMed ID: 56002
    [No Abstract]   [Full Text] [Related]  

  • 55. Control of refractory cardiac arrhythmias with amiodarone.
    Leak D; Eydt JN
    Arch Intern Med; 1979 Apr; 139(4):425-8. PubMed ID: 434996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Amiodarone in the bradycardia-tachycardia syndrome. 2-year follow-up].
    Conte MR; Gaita F; Asteggiano R; Bocchiardo M; Rosettani E
    Cardiologia; 1982; 27(6):581-6. PubMed ID: 6892438
    [No Abstract]   [Full Text] [Related]  

  • 57. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Amiodarone in the treatment of severe supraventricular tachycardias].
    Lukl J; Cernosek B; Rezácová M; Heinc P
    Vnitr Lek; 1986 Apr; 32(4):386-92. PubMed ID: 3727426
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
    Saksena S; Rothbart ST; Cappello G
    Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [ECG observations on terminating tachyarrhythmia by intravenous amiodarone].
    Xu ML
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Mar; 13(1):14-6. PubMed ID: 4006697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.